3Aljubran A, Leighl N, Pintilie M, et al. Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer. Hematol Oncol Stem Cell Ther,2009 ,2 :265-271.
4Cardoso F, Bedard PL, Winer EP, et al. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst,2009,101 : 1174-1181.
5Chan TY, Tomlinson B, Tse LK, et al. Aeonitine poisoning due to Chinese herbal medicines : a review. Vet Hum Toxicol, 1994,36:452-455.
6Hazawa M, Wada K, Takahashi K, et al. Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth. Invest New Drugs ,2009,27 : 111-119.
4Gibson MK,Li Y,Murphy B,et al.Randomized phase Ⅲ evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395):an intergroup trial of the Eastern Cooperative Oncology Group[J].J Clin Oncol,2005,23(15):3562-3567.
5Benasso M,Ponzanelli A,Medano M,et al.Paclitaxel,cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck:a phase Ⅱ trial from an Italian cooperative group[J].Acta Oncol,2006,45(2):168-174.
6Schena M,Barone C,Birocco N,et al.Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma:a phase Ⅱ study[J].Cancer Chemother Pharmacol,2005,55(3):271-276.
7Jacobs C,Lyman G,Velez-Garcia E,et al.A phase Ⅲ randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck[J].J Clin Oncol,1992,10(2):257-263.
8Forastiere AA,Metch B,Schulter DE,et al.Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck:a Southwest Oncology Group study[J].J Clin Oncol,1992,10(8):1245-1251.
